WO2000074693A2 - Immunity generation - Google Patents

Immunity generation Download PDF

Info

Publication number
WO2000074693A2
WO2000074693A2 PCT/GB2000/002238 GB0002238W WO0074693A2 WO 2000074693 A2 WO2000074693 A2 WO 2000074693A2 GB 0002238 W GB0002238 W GB 0002238W WO 0074693 A2 WO0074693 A2 WO 0074693A2
Authority
WO
WIPO (PCT)
Prior art keywords
immunity
medicament
insects
superfamily
biological waste
Prior art date
Application number
PCT/GB2000/002238
Other languages
French (fr)
Other versions
WO2000074693A3 (en
Inventor
Christopher Jeremy Leonard
Original Assignee
Bondco 897 Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bondco 897 Limited filed Critical Bondco 897 Limited
Priority to JP2001501227A priority Critical patent/JP2003531100A/en
Priority to GB0129568A priority patent/GB2368016B/en
Priority to AU52377/00A priority patent/AU777226B2/en
Priority to CA002373277A priority patent/CA2373277A1/en
Priority to EP00937086A priority patent/EP1191938A2/en
Publication of WO2000074693A2 publication Critical patent/WO2000074693A2/en
Publication of WO2000074693A3 publication Critical patent/WO2000074693A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/20Animal feeding-stuffs from material of animal origin
    • A23K10/26Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/10Animals; Substances produced thereby or obtained therefrom
    • A01N63/14Insects
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C05FERTILISERS; MANUFACTURE THEREOF
    • C05FORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C, e.g. FERTILISERS FROM WASTE OR REFUSE
    • C05F17/00Preparation of fertilisers characterised by biological or biochemical treatment steps, e.g. composting or fermentation
    • C05F17/05Treatments involving invertebrates, e.g. worms, flies or maggots
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/141Feedstock
    • Y02P20/145Feedstock the feedstock being materials of biological origin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02WCLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W30/00Technologies for solid waste management
    • Y02W30/40Bio-organic fraction processing; Production of fertilisers from the organic fraction of waste or refuse

Definitions

  • This invention relates to immunity generation.
  • the invention also relates to the treatment and/or prevention of allergies.
  • the invention also relates to the use of insects, including larval forms and other life forms, in the recycling of biological waste.
  • the invention further relates to the use of insects and their larvae as a food source.
  • a method for the manufacture of a medicament for immunity generation and/or treatment and/or prevention of allergies which method includes the use of insect tissues and/or larval forms and derivatives of insects.
  • a medicament for the provision of immunity to bacterial and viral disease and/or allergies and/or tumours comprising insect tissues and/or larval forms and derivatives of insects.
  • the medicament may be in a form which permits its ingestion, digestion and assimilation to provide immunity to bacterial and viral disease and/or allergies and/or tumours.
  • the medicament may alternatively be in a form which permits its injection into the subject to which or whom the immunity is to be given.
  • the medicament may be in a form which permits its absorption transcutaneously.
  • the medicament may alternatively be in a form which is suitable for ingestion, digestion and assimilation by a nursing mother for provision of immunity to a baby being breast-fed.
  • the subject may be bird or an animal, including humans.
  • a method of recycling biological waste which includes the use of insects, including larval and other life forms, to produce either a medicament having immunity-generating properties or a food source which has immunity-generating properties.
  • the biological waste may be sewage, paper, vegetable and organic materials.
  • Typical waste materials include animal offal and residue from the meat processing industry. They also include deceased diseased animals, such as those infected with BSE.
  • a method of producing a food source which includes the use of insects and their la ⁇ ae which act as carriers providing immunity generation as well as protein, energy and biologically active beneficial compounds.
  • beneficial compounds include vitamins, omega 3 unsaturated fatty acids, trace elements, minerals and amino-acids, such as methionine, lysine, isoleucine and phenylalanine.
  • insects and their larvae have adapted by evolution to become biological recyclers. In this role they have developed an ability to metabolise faecal matter, dead, decaying and diseased animal remains. This has necessitated an ability on their part to withstand bacterial and viral attack from the food on which they feed, and in this way they have developed a successful immune strategy.
  • insects to be used are grown on a substrate inoculated with the relevant bacteria or virus when pursuing specific immuniological responses.
  • Relevant substrates would be used when biologically recycling, for example, sewage.
  • insects to be used if grown on a substrate of mixed bacteria, will provide a general raised level of anti-bacterial activity, providing general immunity to the recipient consumer.
  • the particular bacteria in question will be used in the substrate. This will promote the particular lectins and induce peptides that are suitable for its control.
  • the ingestion of the insect plus the residual bacteria will provide a means for the induction of the auto-immune system of the recipient consumer.
  • the immune response adaptability will be shown particularly amongst carrion and detritus feeders.
  • the viability of the process is largely dependant on the ability to produce readily, large quantities and volumes of the insects of the species that are listed below. It is believed that flies, in their la ⁇ al form, maggots, are the most suitable, as they have a short life span and high fecundity. Also, they have a natural inactivated inert phase - the pupa stage.
  • Muscidae I House flies common house fly Musca domestica common house fly Faffia Canicularis lesser house fly green cluster fly Dasyphora Cyanella II. Blow flies Calliphoridae blue bottle Calliphora Erythrocephalia Calliphora Vomitoria green bottle Lucilia Sericata Lucilia Caesar flesh fly Sarcophaga Camaria
  • Tuberculosis Mycobacterium Tubercularis
  • Sewage Waste Organic waste from abattoirs, meat processing plants (cattle, sheep, pigs, poultry and including diseased animals, fish and shellfish, e.g. crabs, mussels, whelks and scallops).
  • the invention thus provides a method of eliminating the need for landfill or incineration in that insects can be introduced into land containing waste materials so as to enrich the soil and provide a slow release of nitrogen compounds.
  • the procedure will also enable 'fishy tastes' to be eliminated, when feeding insects fed on fish waste to chickens.
  • An important application of the present invention is thus the feeding of insects to chickens to generate innate immunity in the chickens, with the result that the eggs from the chickens are of improved quality.
  • the innate immunity generated in the chickens can be transferred to the consumers of both the chickens and the eggs laid by the chickens.
  • the antibacterial agents in the slime of worms migrates to the skin of a worm for transfer to the soil, and hence may be absorbed by plant roots and, in this way, promote the health of the plants, providing a feedback mechanism between species members (plants) after one has succumbed to disease promoting a strengthening of the plant population (as with the animal kingdom).
  • the procedure will also provide a source of trace elements and minerals, including
  • the invention is also applicable to the following swine diseases, i.e. dysentry, swine erysipeala, African swine fever, swine influenza, swine plague, swine pox and SVD.
  • swine diseases i.e. dysentry, swine erysipeala, African swine fever, swine influenza, swine plague, swine pox and SVD.
  • protection can be obtained against actinacillosis, actinomycosis, anthrax, foot and mouth disease, brucellosis, coccidosis, pleuro-pneumonia, bovine encephalomyelitis, cattle plague, blouwildebeesoog, cerebrocortical necrosis, clostrial entiritis, Johne's disease, rabies, salmonellosis, skinTB, tick- borne fever, tuberculosis, viral entiritis, virus infections of cows' teats, vulvo-vaginitismastitis, polioencephalomalacia, parasitic gastroentiritis, milk fever, red water, hypocupraemia, hypomagnesaemic disease, infectious ophthalmic disease, part-parturient haemoglobinuria, mucormycosis, mucosaldis and pyelonephritis.
  • It can also serve as a growth promoter, a means of prevention of allergies and a means for preventing or inhibiting the development and growth of tumours.
  • an egg As a food form, it enriches the eggs that are produced from chickens. With correct use of the substrate for insects, an egg can be produced which contains: a) Omega 3 unsaturated fatty acids, but without the fatty taste, and. b) Other biologically beneficial compounds. See Above.
  • molluscs can be fed on decaying waste for the generation of an innate immune response in the molluscs, which innate immunity can then be transferred to fish and to those who feed on fish.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)

Abstract

Immunity generation is effected by a method which includes the use of insect tissues and/or larval forms and derivatives of insects. The invention also provides a method of producing a food source which includes the use of insects and their larvae which act as carriers providing immunity generation as well as protein, energy and biologically active beneficial compounds.

Description

IMMUNITY GENERATION
Field of the Invention
This invention relates to immunity generation. The invention also relates to the treatment and/or prevention of allergies.
The invention also relates to the use of insects, including larval forms and other life forms, in the recycling of biological waste.
The invention further relates to the use of insects and their larvae as a food source.
Summary of the Invention
According to a first aspect of the present invention there is provided a method for the manufacture of a medicament for immunity generation and/or treatment and/or prevention of allergies, which method includes the use of insect tissues and/or larval forms and derivatives of insects.
According to a second aspect of the present invention there is provided a medicament for the provision of immunity to bacterial and viral disease and/or allergies and/or tumours, said medicament comprising insect tissues and/or larval forms and derivatives of insects.
The medicament may be in a form which permits its ingestion, digestion and assimilation to provide immunity to bacterial and viral disease and/or allergies and/or tumours. The medicament may alternatively be in a form which permits its injection into the subject to which or whom the immunity is to be given. As a further alternative, the medicament may be in a form which permits its absorption transcutaneously.
The medicament may alternatively be in a form which is suitable for ingestion, digestion and assimilation by a nursing mother for provision of immunity to a baby being breast-fed.
The subject may be bird or an animal, including humans.
According to a third aspect of the present invention there is provided a method of recycling biological waste which includes the use of insects, including larval and other life forms, to produce either a medicament having immunity-generating properties or a food source which has immunity-generating properties.
The biological waste may be sewage, paper, vegetable and organic materials. Typical waste materials include animal offal and residue from the meat processing industry. They also include deceased diseased animals, such as those infected with BSE. According to a fourth aspect of the present invention there is provided a method of producing a food source which includes the use of insects and their laπ ae which act as carriers providing immunity generation as well as protein, energy and biologically active beneficial compounds.
Such beneficial compounds include vitamins, omega 3 unsaturated fatty acids, trace elements, minerals and amino-acids, such as methionine, lysine, isoleucine and phenylalanine.
Description of the Preferred Embodiments
Certain species of insects and their larvae have adapted by evolution to become biological recyclers. In this role they have developed an ability to metabolise faecal matter, dead, decaying and diseased animal remains. This has necessitated an ability on their part to withstand bacterial and viral attack from the food on which they feed, and in this way they have developed a successful immune strategy.
For the success of the animal kingdom as a whole, it is imperative that disease should not become rampant and be spread from the ingestion of the animals which feed on them.
The ingestion and digestion of insects by higher animals of the food chain provide a pathway for the transfer of immunity up the food chain. In the move towards a more concerned approach to our environment, we need to work more closely in tandem with it. This requires a greater understanding of the way of the natural world.
In our husbandry of animals for food, we must, as far as is possible, return to a feeding regime that is more like the original regime from which the animals have developed.
It has been observed that, in the nutrition of the human species, the feeding of simple food substitutes in the form of concentrates, although providing all the basic nutritional requirements, has led to problems in the digestive tract, and a diminution of the health of the individual as exhibited by, for example, the growth in numbers of alimentary tract cancers.
What the human animal requires is good wholesome food. To ensure this, we must examine and promote the well-being of the animals on which we feed.
In the natural environment the circuit of life succeeds and we must understand and promote this relationship. In the control of disease in man, we have ventured along the path of specific arA bacterial, anti-viral drug protection. In contrast, the r ^sent invention is concerned with the development of an immune system that is initiated by charging it by the ingesti n of foods in which immunity has been created naturally. METHOD AND PROCEDURE
The insects to be used are grown on a substrate inoculated with the relevant bacteria or virus when pursuing specific immuniological responses. Relevant substrates would be used when biologically recycling, for example, sewage.
The insects to be used, if grown on a substrate of mixed bacteria, will provide a general raised level of anti-bacterial activity, providing general immunity to the recipient consumer. In the incidence of requiring specific immuno-response, then the particular bacteria in question will be used in the substrate. This will promote the particular lectins and induce peptides that are suitable for its control. Under the circumstances that not all of the bacteria are destroyed by the insect's immune system, the ingestion of the insect plus the residual bacteria will provide a means for the induction of the auto-immune system of the recipient consumer.
Presentation of the bacterial- and/or viral-resistant insects would be:-
1 whole and live, or
2 inactivated whole, or
3 homogenised whole, or
4 sectional preparation, or
5 pupated whole live, or
6 pupated whole inactivated.
In the feeding of the insects as a food form it will be optimal to provide and present a food which does not need additional antioxidants and preservatives, as this tends to defeat the philosophy behind the concept.
The extraction of specific anti-viral and anti-bacterial activity from the insects will necessitate chemical and physical extraction processes, involving the use of stabilisers, solvents, reactants and various separation techniques.
INSECT SOURCE
The immune response adaptability will be shown particularly amongst carrion and detritus feeders. The viability of the process is largely dependant on the ability to produce readily, large quantities and volumes of the insects of the species that are listed below. It is believed that flies, in their laπ al form, maggots, are the most suitable, as they have a short life span and high fecundity. Also, they have a natural inactivated inert phase - the pupa stage.
SPECIES
TRUE FLIES
Muscidae I. House flies common house fly Musca domestica common house fly Faffia Canicularis lesser house fly green cluster fly Dasyphora Cyanella II. Blow flies Calliphoridae blue bottle Calliphora Erythrocephalia Calliphora Vomitoria green bottle Lucilia Sericata Lucilia Caesar flesh fly Sarcophaga Camaria
III. seaweed fly Coelopidae Coelopa Fridda
IV. fruit flies Drosophilia
V. crane flies Tipulidae
VI. mosquitoes Culicidae Andphelline
VII. soldier flies Stratiomyidae
VIII. horseflies Tabanidae
IX. robber flies Asilidae
X. hover flies Syrphidae Tephritidae
XI. louse flies Hippoboscidae Tachinidae
XII. sewage flies Diptera
2 cave crickets Rhaphidophoridae
3 cockroaches Dictyptera
4 earwigs Dermaptera
5 ground beetles Carabidae burying beetles Silphidae rove beetles Staphylinidae scarabs and chafers Scrabaeidae click beetles Elateridae larder beetle Dermestidae church tard beetle
6 centipedes Chilopoda millipedes Diplopodia
7 harvestmen Opillionis
8 Series Schizophora
9 moths and butterflies Lepidoptera
Superfamily Hesperioidea Superfamily Papillonoidea Superfamily Micropterigoidea Superfamily Eriocranioidea Superfamily Hepialoidea Superfamily Nepticuloidea/Stigmelloidea Superfamily Incurvaroidea Superfamily Cossoidea Superfamily Zygaenoidea Superfamily Pterophoroidea Superfamily Pyraloidea Superfamily Tortricoidea Superfamily Sesioidea Superfamily Tineoidea Superfamily Alucitoidea Superfamily Noctuoidea Superfamily Geometroidea Superfamily Sphingoidea Superfamily Bombycoidea
Caddis Flies Order Trichoptera
Bees Wasps Ants: Order Hymenoptera:
Superfamily Evanioidies Superfamily Ichneumonoidea Superfamily Cynipoidea Superfamily Chalcidoidea Superfamily Proctotrupoidea Superfamily Ceraphronoidea Superfamily Chrysidoidea Superfamily Scholioidea
The Ants:
Superfamily Formicoidea
The True Wasps:
Superfamily Vespoidea Superfamily Pompiloidea Superfamily Sphecoidea
The Bees:
Superfamily Apoidea
Snails: cochlea
Worms: lumbricus terrestris
Slugs
DISEASES THAT COULD BE INCORPORATED INTO THIS
PROCEDURE
Anthrax Bacillus Antharis Botulism Clostridium Botulinum Cholera Vibrio Choierae Diptheria Coryne Bacterium Diptheriae O 00/74693
11
Food Poisoning Staphylococcus
Bacillus Cerens
Clostridium Perfringens
Salmonella Typhimurium
Gas Gangrene Clostridium Perfringens
Clostridium Novyi
Clostridium Septicum
Gonnorrhoea Neisseria Gonorrhoea
Leprosy Mycocbacterium Leprae
Meningitis Neisseria Meninigitidis
Haemophilus Influenzae
Streptoccus Pneumonial
Listeria Monocytogenes
Bubonic Plague Yersinia Pestis
Pneumonia Streptococcus Pneumoniae
Haemophilus Influenzae
Klebsiella Pneumoniae
Mycoplasm Pneumoniae
Q Fever Coxiella Burneth
Scarlet Fever Streptococcus Pyogenes
Syphilis Treponema Palliduni
Tetanus Clostridium Tetani
Trachoma Chlamydia Trachomatis
Tuberculosis Mycobacterium Tubercularis
Mycobacterium Bovis
Typhoid Salmonella Typhi
Typhus Rickettsia Prowazekit
Measles German measles Rubella
Chicken-pox Varicella
Shingles Herpes Zoster
Common Cold Acute Coryza
Hepatitis
Bee Virus
Influenza
Encephalitis
Mumps
Whooping Cough Burdetella Pertussis
Small-pox Variola
Rabies Hydrophobia
BACTERIAL FAMILIES COVERED BY THE PROCEDURE
Escheria
Salmonella
Arizona Proteus Klebsiella Shicella
Pasteurellayersina Francisella
Bruella
Actinobacillus
Haemophilus Mora & Ella Bordatella
Spharophorus
Staphyloccus
Streptococcus
Pneumococcus
Corynebacterium
Erysipelothrix Listeria
Bacillus
Clostridium
Mycobacterium
Actinomyces
Nocardia
Pseudomanas
Campylobacter
Leptospira
Borrelia Treponema Spirillum
Mycoplasma Achoeplasma
USES AND APPLICATIONS
USES
A. Immunological Transfer:
1) Transfer of bacterial and viral immunity through ingestion, digestion and assimilation of insects, including their larval forms,, in their whole form or processed to recipient.
2)Transfer of bacterial or viral immunity through inoculation of active extracts from the tissues of insects and their larvae to the recipient.
B. As Protein and Organic Recyclers Substrates:-
1. Sewage Waste. 2. Organic waste from abattoirs, meat processing plants (cattle, sheep, pigs, poultry and including diseased animals, fish and shellfish, e.g. crabs, mussels, whelks and scallops).
3. Vegetable waste, from the food industry and manufacturers including brewing.
4. Wood pulp waste.
5. Household waste.
6. Seaweed.
The invention thus provides a method of eliminating the need for landfill or incineration in that insects can be introduced into land containing waste materials so as to enrich the soil and provide a slow release of nitrogen compounds.
C Animal Nutrition
Provision through suitable substrates of:
1) Protein Source
2) Lysine, Methionine & Isolucene in particular, as well as other amino acids.
3) Vitamin Source:- Bi Anevrin
B2 Riboflavin B3 Niacin B5 B6
Folic acid Pantothenic Biotin
C
D
E
K
4) DMAE
5) Various Fatty Acids
Saturated but in particular unsaturated:-
RAC
Palmitoleic
Oleic
Linoleic
Arichidonic Acid
Nervonic Acid
Ximenyic myomycin
Long Chain Fatty Acids
Omega 3 unsaturated Fatty Acids
With the correct choice of insects, it will be possible to reduce oxidised unsaturated fatty acids and thus eliminate unsuitable rancid flavoured fatty acids from the food chain, returning the fatty acids to their prior double bond unsaturated state.
The procedure will also enable 'fishy tastes' to be eliminated, when feeding insects fed on fish waste to chickens. An important application of the present invention is thus the feeding of insects to chickens to generate innate immunity in the chickens, with the result that the eggs from the chickens are of improved quality. In addition, the innate immunity generated in the chickens can be transferred to the consumers of both the chickens and the eggs laid by the chickens.
Insects living in soil digest and assimilate plant protein including that which has been attacked by fungi. It is accordingly possible to feed the insects on specifically chosen plant protein to produce a desired innate immune response. In addition, the antibacterial agents in the slime of worms migrates to the skin of a worm for transfer to the soil, and hence may be absorbed by plant roots and, in this way, promote the health of the plants, providing a feedback mechanism between species members (plants) after one has succumbed to disease promoting a strengthening of the plant population (as with the animal kingdom).
The biological and digestion processes of the insect larvae will also degrade BSE proteins into their component amino aids.
The procedure will also provide a source of trace elements and minerals, including
Se Selenium, Fe Iron, Mn Manganese, I Iodine, Ca Calcium, S Sulphur, K Potassium, Na Sodium, P Phosphorus and Cu Copper
APPLICATIONS
1) Control of disease in man by boosting the innate immunity system and aiding the induction of the auto-immune system. 2) Control of disease in animals and fish. Thus, for poultry, protection can be obtained against avian infectious encephalomyelitis, avian listeriosis, avian plague, avian TB, avian bumblefoot, cage layer fatigue, coccidiosis, E coli, favus, fowl cholera, fowl paralysis, fowl typhoid, gapes, haemorrhagic disease, moniliasis, Newcastle disease, pullet disease, pullorum disease, salmonellosis, synovitis, toxic fat syndrome, gumboro, bronchitis, nephrosis, liver/kidney syndrome, Marek's disease and infestation with trichostrongylus axei. The invention is also applicable to the following swine diseases, i.e. dysentry, swine erysipeala, African swine fever, swine influenza, swine plague, swine pox and SVD. For cattle, protection can be obtained against actinacillosis, actinomycosis, anthrax, foot and mouth disease, brucellosis, coccidosis, pleuro-pneumonia, bovine encephalomyelitis, cattle plague, blouwildebeesoog, cerebrocortical necrosis, clostrial entiritis, Johne's disease, rabies, salmonellosis, skinTB, tick- borne fever, tuberculosis, viral entiritis, virus infections of cows' teats, vulvo-vaginitismastitis, polioencephalomalacia, parasitic gastroentiritis, milk fever, red water, hypocupraemia, hypomagnesaemic disease, infectious ophthalmic disease, part-parturient haemoglobinuria, mucormycosis, mucosaldis and pyelonephritis.
3) As a food base in chickens. When given whole to chickens in a free-range environment, it provides a mode of feeding which promotes foraging and scratching. This also promotes grass and natural vegetation consumption, lessens aggressive behaviour, by satisfying basic pecking response, eliminating the need for beak cutting.
4) It can also serve as a growth promoter, a means of prevention of allergies and a means for preventing or inhibiting the development and growth of tumours.
5) As a food form, it enriches the eggs that are produced from chickens. With correct use of the substrate for insects, an egg can be produced which contains: a) Omega 3 unsaturated fatty acids, but without the fatty taste, and. b) Other biologically beneficial compounds. See Above.
It can also produce an egg of lower cholesterol levels, benefiting man, the consumer.
6) As a food source for game and fowl and pheasant, grouse and partridge, particularly in their early development.
Further Applications:
In the recycling of man-made fibres and carbon polymers.
In a marine environment, molluscs can be fed on decaying waste for the generation of an innate immune response in the molluscs, which innate immunity can then be transferred to fish and to those who feed on fish.

Claims

Claims:-
1. A method for the manufacture of a medicament for immunity generation and/or treatment and/or prevention of allergies, which method includes the use of insect tissues and/or larval forms and derivatives of insects.
2. A medicament for the provision of immunity to bacterial and viral disease and/or allergies and/or tumours, said medicament comprising insect tissues and/or larval forms and derivatives of insects.
3. A medicament as claimed in Claim 2, which is in a form which permits its ingestion, digestion and assimilation.
4. A medicament as claimed in Claim 2, which is in a form which permits its injection into the subject to which or whom the immunity is to be given.
5. A medicament as claimed in Claim 2, which is in a form which permits its absorption transcutaneously.
6. A method of recycling biological waste which includes the use of insects, including larval and other life forms, to produce either a medicament having immunity-generating properties or a food source which has immunity-generating properties.
7. A method as claimed in Claim 6, in which the biological waste is or includes sewage.
8. A method as claimed in Claim 6, in which the biological waste is or includes animal offal.
9. A method as claimed in Claim 6, in which the recycling of the biological waste material is effected on land which is enriched by the recycling process.
10. A method of producing a food source which includes the use of insects and their larvae which act as carriers providing immunity generation as well as protein, energy and biologically active beneficial materials.
11. A method of raising chickens, which includes feeding the chickens on the food source produced by the method of Claim 10.
12. A method of promoting the growth of plants in soil and increasing the resistance of the plants to fungal attack, which includes the addition of the end product of the method of Claim 6 to the soil.
PCT/GB2000/002238 1999-06-09 2000-06-08 Immunity generation WO2000074693A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2001501227A JP2003531100A (en) 1999-06-09 2000-06-08 Immunity generation
GB0129568A GB2368016B (en) 1999-06-09 2000-06-08 Immunity generation
AU52377/00A AU777226B2 (en) 1999-06-09 2000-06-08 Immunity generation
CA002373277A CA2373277A1 (en) 1999-06-09 2000-06-08 Immunity generation
EP00937086A EP1191938A2 (en) 1999-06-09 2000-06-08 Immunity generation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9913267.2 1999-06-09
GB9913267A GB9913267D0 (en) 1999-06-09 1999-06-09 Immunity generation

Publications (2)

Publication Number Publication Date
WO2000074693A2 true WO2000074693A2 (en) 2000-12-14
WO2000074693A3 WO2000074693A3 (en) 2001-06-28

Family

ID=10854922

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/002238 WO2000074693A2 (en) 1999-06-09 2000-06-08 Immunity generation

Country Status (6)

Country Link
EP (1) EP1191938A2 (en)
JP (1) JP2003531100A (en)
AU (1) AU777226B2 (en)
CA (1) CA2373277A1 (en)
GB (2) GB9913267D0 (en)
WO (1) WO2000074693A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2379875A (en) * 2001-07-23 2003-03-26 Christopher Jeremy Leonard Immunity generation
DE102006000672A1 (en) * 2006-01-03 2007-07-05 Halbritter, Andres Ludovico, Dr. Production of a biocatalyst from natural source, useful e.g. to increase the growth of organisms, comprises producing a biocatalyst from ants, allocating the biocatalyst in an alcohol, and separating the biocatalyst
CN104884068A (en) * 2012-07-27 2015-09-02 株式会社爱南自由 Polysaccharide, composition containing polysaccharide, and immunostimulating agent
WO2016079463A1 (en) * 2014-11-19 2016-05-26 Immune Macro-Biotic Technology Uk Limited Immunity generation
CN112586637A (en) * 2021-01-06 2021-04-02 河南省农业科学院植物保护研究所 Artificial feed for earwigs and preparation and feeding methods thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009015358B4 (en) 2009-03-27 2015-01-15 Adam Obersat Screw, screwing tool and their use for the manufacture of dental prostheses
DE202009009500U1 (en) 2009-07-11 2009-11-26 Obersat, Adam Screw profile for use with dental implants, in particular abutment screw or gingiva former
JP2012139107A (en) * 2010-12-15 2012-07-26 Nakahara Co Ltd Health food showing relaxation activity in atopic dermatitis-like dermatitis
WO2017213172A1 (en) * 2016-06-07 2017-12-14 国立大学法人愛媛大学 Method for production of composition

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB874297A (en) * 1959-11-13 1961-08-02 Ruprecht Claus Feeding mixtures for tropical birds
US3814057A (en) * 1971-02-08 1974-06-04 Us Agriculture Separator for negatively phototactic house fly larvae from chicken hen excreta
EP0073173A1 (en) * 1981-08-21 1983-03-02 Monique née Perrier Lemonnier Products extracted from invertebrate sea-animals, their preparation and their uses in dietetics,pharmaceutics and cosmetology
US4405602A (en) * 1980-01-21 1983-09-20 Cooperativa Agricola De Productie Scornicesti Process for the obtainment of a biologically active bee-product
EP0093195A1 (en) * 1982-04-26 1983-11-09 Monique née Perrier Lemonnier Product on the basis of invertebrated sea animals, process for its preparation and its use as animal food or fertilizer
DE3611791A1 (en) * 1986-04-08 1987-10-22 Wolfgang Michel Process for producing protein-containing material, in particular animal feed, and protein-containing material
WO1992000258A1 (en) * 1990-07-02 1992-01-09 Bruce Silcock Treatment of waste animal materials
DE4111782A1 (en) * 1991-04-11 1992-10-15 Gerhard Bayer Strengthening the immune system with propolis resin - dissolved in high strength ethanol@ to protect against bacterial and esp. viral infections
DE4211745A1 (en) * 1992-04-03 1993-10-07 Boerner Gmbh Use of propolis as antiinflammatory agent - to inhibit release of inflammation mediators from inflammatoric cells e.g. in treatment of lung diseases
DE19543513A1 (en) * 1995-11-22 1997-06-12 Andreas Clemens Agent for treating human immuno-deficiency virus infection
EP1006124A1 (en) * 1998-12-02 2000-06-07 Entopharm Co., Ltd. Immunomodulatory and antimicrobial materials, their preparation and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4211782A1 (en) * 1992-04-08 1993-10-14 Basf Ag Process for the preparation of di- or triarylmethane dyes

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB874297A (en) * 1959-11-13 1961-08-02 Ruprecht Claus Feeding mixtures for tropical birds
US3814057A (en) * 1971-02-08 1974-06-04 Us Agriculture Separator for negatively phototactic house fly larvae from chicken hen excreta
US4405602A (en) * 1980-01-21 1983-09-20 Cooperativa Agricola De Productie Scornicesti Process for the obtainment of a biologically active bee-product
EP0073173A1 (en) * 1981-08-21 1983-03-02 Monique née Perrier Lemonnier Products extracted from invertebrate sea-animals, their preparation and their uses in dietetics,pharmaceutics and cosmetology
EP0093195A1 (en) * 1982-04-26 1983-11-09 Monique née Perrier Lemonnier Product on the basis of invertebrated sea animals, process for its preparation and its use as animal food or fertilizer
DE3611791A1 (en) * 1986-04-08 1987-10-22 Wolfgang Michel Process for producing protein-containing material, in particular animal feed, and protein-containing material
WO1992000258A1 (en) * 1990-07-02 1992-01-09 Bruce Silcock Treatment of waste animal materials
DE4111782A1 (en) * 1991-04-11 1992-10-15 Gerhard Bayer Strengthening the immune system with propolis resin - dissolved in high strength ethanol@ to protect against bacterial and esp. viral infections
DE4211745A1 (en) * 1992-04-03 1993-10-07 Boerner Gmbh Use of propolis as antiinflammatory agent - to inhibit release of inflammation mediators from inflammatoric cells e.g. in treatment of lung diseases
DE19543513A1 (en) * 1995-11-22 1997-06-12 Andreas Clemens Agent for treating human immuno-deficiency virus infection
EP1006124A1 (en) * 1998-12-02 2000-06-07 Entopharm Co., Ltd. Immunomodulatory and antimicrobial materials, their preparation and use

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2379875A (en) * 2001-07-23 2003-03-26 Christopher Jeremy Leonard Immunity generation
DE102006000672A1 (en) * 2006-01-03 2007-07-05 Halbritter, Andres Ludovico, Dr. Production of a biocatalyst from natural source, useful e.g. to increase the growth of organisms, comprises producing a biocatalyst from ants, allocating the biocatalyst in an alcohol, and separating the biocatalyst
CN104884068A (en) * 2012-07-27 2015-09-02 株式会社爱南自由 Polysaccharide, composition containing polysaccharide, and immunostimulating agent
WO2016079463A1 (en) * 2014-11-19 2016-05-26 Immune Macro-Biotic Technology Uk Limited Immunity generation
CN107073045A (en) * 2014-11-19 2017-08-18 英国大型生物免疫技术有限公司 Immunity is formed
GB2547602A (en) * 2014-11-19 2017-08-23 Immune Macro-Biotic Tech Uk Ltd Immunity generation
US10383899B2 (en) 2014-11-19 2019-08-20 Mmune Macro-Biotic Technology Uk Limited Immunity generation
AU2015348150B2 (en) * 2014-11-19 2021-05-06 Immune Macro-Biotic Technology Uk Limited Immunity generation
CN107073045B (en) * 2014-11-19 2021-06-11 英国大型生物免疫技术有限公司 Development of immunity
AU2021209255B2 (en) * 2014-11-19 2023-07-27 Immune Macro-Biotic Technology Uk Limited Immunity generation
CN112586637A (en) * 2021-01-06 2021-04-02 河南省农业科学院植物保护研究所 Artificial feed for earwigs and preparation and feeding methods thereof
CN112586637B (en) * 2021-01-06 2022-10-11 河南省农业科学院植物保护研究所 Artificial feed for earwigs and preparation and feeding methods thereof

Also Published As

Publication number Publication date
WO2000074693A3 (en) 2001-06-28
JP2003531100A (en) 2003-10-21
AU777226B2 (en) 2004-10-07
GB2368016A (en) 2002-04-24
GB2368016B (en) 2004-09-01
GB0129568D0 (en) 2002-01-30
AU5237700A (en) 2000-12-28
EP1191938A2 (en) 2002-04-03
GB9913267D0 (en) 1999-08-04
CA2373277A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
van Huis Edible insects
Waiho et al. Larval rearing of mud crab (Scylla): What lies ahead
Kenis et al. Insects used for animal feed in West Africa
US10412937B2 (en) Marine material derived from early developmental stages of barnacles
EGGERT et al. Parental care improves offspring survival and growth in burying beetles
Elahi et al. Insect meal as a feed ingredient for poultry
Rossi et al. Role of fungi in the trophic niche of the congeneric detritivorous Asellus aquaticus and A. coxalis (Isopoda)
CN106577488A (en) Duck breeding method
AU777226B2 (en) Immunity generation
JP2011234701A (en) Method for producing nutritive material including pupa of house fly
Trager The nutrition of invertebrates
Shelomi Nutrient composition of black soldier fly (Hermetia illucens)
AU2014393411B2 (en) Selecting, producing, and feeding whole algae as a feed supplement for cattle and bison to produce meat high in Omega 3's for human health
JP2003219761A (en) Disposal method for vegetable food waste using larva of insect of genus lepidoptera of family noctuidae and feed using product thereof
WO1995026633A2 (en) Insects' egg-laying substrate
Racioppi et al. THE EFFECTS OF VARIOUS OLIGIDIC SYNTHETIC DIETS ON THE GROWTH OF HIPPODAMIA CONVERGENS 1
US20050277578A1 (en) Immunity generation
JPH06113750A (en) Organism feed for fishes and shellfishes and its production
Drew et al. The biology and behavior of flies in the tribe Dacini (Dacinae)
Mutlag et al. Assessment of the addition of oyster mushroom (Pleurotus ostreatus) on the weights sectors ratios and giblets weight of broiler chicken and microbial contents
Syromyatnikov et al. Recycling biological waste using the fly Hermetia illucens, environmental risks and biosafety for Russia
Barcelo Production and utilisation of earthworms as feeds for broilers in the Philippines
CN113678762B (en) Prevention and control method for skin rot of carnivorous fish
Allotey Current status of entomophagy in Africa.
KR19990040962A (en) Fish farming and fry farming methods for improving the immunity of fry

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2373277

Country of ref document: CA

Ref country code: CA

Ref document number: 2373277

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 501227

Kind code of ref document: A

Format of ref document f/p: F

Ref country code: GB

Ref document number: 200129568

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000937086

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 52377/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 516499

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 10009438

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000937086

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 52377/00

Country of ref document: AU

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)